HIV-1 Limiting Antigen (LAg) Avidity DBS EIA Kit, 192 Tests

The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term.

 

The Maxim HIV-1 LAg-Avidity DBS EIA uses US CDC developed technology and is designed for surveillance purposes such as estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence populations so that prevention research, vaccine trials, and resources are most appropriately utilized.

 

This product is for research use only and is not intended for use in diagnostic procedures.

Catalog #: 92003

92003 LAg Kit with Components
92003 LAg Kit with Components

press to zoom
92003 Box
92003 Box

press to zoom
92003 Frozen Pack
92003 Frozen Pack

press to zoom
92003 LAg Kit with Components
92003 LAg Kit with Components

press to zoom
1/3

ADDITIONAL INFORMATION